Compare $BRTX vs $GOVX | Chartloom

Compare

$BRTX vs $GOVX

BioRestorative Therapies Inc · GeoVax Labs Inc

BRTX

BioRestorative Therapies Inc

GOVX

GeoVax Labs Inc

Compare $BRTX vs $GOVX

Comparing BioRestorative Therapies Inc and GeoVax Labs Inc

BRTXBioRestorative Therapies Inc

GOVXGeoVax Labs Inc

BRTXBioRestorative Therapies Inc

Market cap

$49M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-8.5%

YTD performance

-92.2%

52W performance

-94.2%

FCF yield

-24.4%

GOVXGeoVax Labs Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

-94.6%

52W performance

-98.1%

FCF yield

-950.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BRTX

GOVX

Detailed metrics comparison

BRTX

BioRestorative Therapies Inc

GOVX

GeoVax Labs Inc

Market Cap

BRTX$49M

GOVX$2M

Enterprise Value

BRTX$46M

GOVX$-1M

Price

BRTX$1.91

GOVX$0.28

P/E Ratio

BRTXN/A

GOVXN/A

P/S Ratio

BRTX135.98x

GOVX0.53x

EV/Sales

BRTX127.28x

GOVX0.01x

EV/EBITDA

BRTX0.00x

GOVX0.00x

P/B Ratio

BRTX0.98x

GOVX1.84x

P/FCF Ratio

BRTXN/A

GOVXN/A

EV/FCF

BRTX-3.83x

GOVX0.05x

PEG Ratio

BRTXN/A

GOVXN/A

Forward P/E (NTM)

BRTXN/A

GOVXN/A

Forward P/S (NTM)

BRTXN/A

GOVXN/A

Revenue (TTM)

BRTX$358K

GOVX$0

Revenue Growth (YoY)

BRTX-8.5%

GOVX-100.0%

Forward Rev Growth

BRTX64.6%

GOVX0.0%

Gross Margin (TTM)

BRTX92.1%

GOVX0.0%

Operating Margin (TTM)

BRTX0.0%

GOVX0.0%

EBITDA Margin (TTM)

BRTX-3915.8%

GOVX0.0%

Net Margin (TTM)

BRTX-3089.3%

GOVX0.0%

FCF Margin (TTM)

BRTX-3324.3%

GOVXN/A

Net Income (TTM)

BRTX$-11M

GOVX$-20M

FCF (TTM)

BRTX$-12M

GOVX$-20M

EPS (TTM)

BRTX-$12.47

GOVX-$4.47

ROE (TTM)

BRTX-42384.0%

GOVX-74366.0%

ROA (TTM)

BRTX-19330.0%

GOVX-39473.0%

ROIC (TTM)

BRTX-42384.0%

GOVX-74366.0%

Cash

BRTX$3M

GOVX$3M

Debt

BRTX$0

GOVX$0

Net Cash/Debt

BRTX$3M

GOVX$3M

Current Ratio (TTM)

BRTX2.35x

GOVX1.54x

Quick Ratio (TTM)

BRTX2.23x

GOVX1.16x

Debt/Equity (TTM)

BRTX0.00x

GOVX0.00x

Debt/Assets (TTM)

BRTX0.0%

GOVX0.0%

Interest Coverage (TTM)

BRTXN/A

GOVXN/A

Net Debt/EBITDA (TTM)

BRTX0.00x

GOVX0.00x

Beta

BRTX0.80

GOVX3.89

52W Performance

BRTX-94.2%

GOVX-98.1%

YTD Performance

BRTX-92.2%

GOVX-94.6%

% from 52W High

BRTX-94.5%

GOVX-98.2%

% from 52W Low

BRTX9.1%

GOVX3.9%

Asset Turnover (TTM)

BRTX0.06x

GOVX0.69x

FCF Yield (TTM)

BRTX-24.4%

GOVX-950.7%

Earnings Yield (TTM)

BRTX-22.7%

GOVX-986.3%

Dividend Yield (TTM)

BRTXN/A

GOVXN/A

Rule of 40

BRTX-3,332.8

GOVX-100.0

EV/GP/RG

BRTX2.12

GOVXN/A

Ticker research

View BRTX research View GOVX research

Metric	BRTX BioRestorative Therapies Inc	GOVX GeoVax Labs Inc
Market & Valuation
Market Cap	$49M	$2M
Enterprise Value	$46M	$-1M
Price	$1.91	$0.28
P/E Ratio	N/A	N/A
P/S Ratio	135.98x	0.53x
EV/Sales	127.28x	0.01x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.98x	1.84x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.83x	0.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$358K	$0
Revenue Growth (YoY)	-8.5%	-100.0%
Forward Rev Growth	64.6%	0.0%
Profitability
Gross Margin (TTM)	92.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-3915.8%	0.0%
Net Margin (TTM)	-3089.3%	0.0%
FCF Margin (TTM)	-3324.3%	N/A
Net Income (TTM)	$-11M	$-20M
FCF (TTM)	$-12M	$-20M
EPS (TTM)	-$12.47	-$4.47
ROE (TTM)	-42384.0%	-74366.0%
ROA (TTM)	-19330.0%	-39473.0%
ROIC (TTM)	-42384.0%	-74366.0%
Financial Health
Cash	$3M	$3M
Debt	$0	$0
Net Cash/Debt	$3M	$3M
Current Ratio (TTM)	2.35x	1.54x
Quick Ratio (TTM)	2.23x	1.16x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.80	3.89
52W Performance	-94.2%	-98.1%
YTD Performance	-92.2%	-94.6%
% from 52W High	-94.5%	-98.2%
% from 52W Low	9.1%	3.9%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.69x
FCF Yield (TTM)	-24.4%	-950.7%
Earnings Yield (TTM)	-22.7%	-986.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,332.8	-100.0
EV/GP/RG	2.12	N/A
Ticker research	View BRTX research	View GOVX research

Valuation

P/S Ratio

GOVX

0.53x

BRTX

135.98x

EV/FCF

BRTX

-3.83x

GOVX

0.05x

Growth & revenue

Revenue Growth TTM

BRTX

-8.5%

GOVX

-100.0%

Forward Revenue Growth

BRTX

64.6%

GOVX

0.0%

Profitability & performance

Gross Margin

BRTX

92.1%

GOVX

0.0%

ROE

BRTX

-42384.0%

GOVX

-74366.0%

FCF Yield %

BRTX

-24.4%

GOVX

-950.7%

52-Week Performance

BRTX

-94.2%

GOVX

-98.1%

Detailed metrics comparison

BRTX

BioRestorative Therapies Inc

GOVX

GeoVax Labs Inc

Market Cap

BRTX$49M

GOVX$2M

Enterprise Value

BRTX$46M

GOVX$-1M

Price

BRTX$1.91

GOVX$0.28

P/E Ratio

BRTXN/A

GOVXN/A

P/S Ratio

BRTX135.98x

GOVX0.53x

EV/Sales

BRTX127.28x

GOVX0.01x

EV/EBITDA

BRTX0.00x

GOVX0.00x

P/B Ratio

BRTX0.98x

GOVX1.84x

P/FCF Ratio

BRTXN/A

GOVXN/A

EV/FCF

BRTX-3.83x

GOVX0.05x

PEG Ratio

BRTXN/A

GOVXN/A

Forward P/E (NTM)

BRTXN/A

GOVXN/A

Forward P/S (NTM)

BRTXN/A

GOVXN/A

Revenue (TTM)

BRTX$358K

GOVX$0

Revenue Growth (YoY)

BRTX-8.5%

GOVX-100.0%

Forward Rev Growth

BRTX64.6%

GOVX0.0%

Gross Margin (TTM)

BRTX92.1%

GOVX0.0%

Operating Margin (TTM)

BRTX0.0%

GOVX0.0%

EBITDA Margin (TTM)

BRTX-3915.8%

GOVX0.0%

Net Margin (TTM)

BRTX-3089.3%

GOVX0.0%

FCF Margin (TTM)

BRTX-3324.3%

GOVXN/A

Net Income (TTM)

BRTX$-11M

GOVX$-20M

FCF (TTM)

BRTX$-12M

GOVX$-20M

EPS (TTM)

BRTX-$12.47

GOVX-$4.47

ROE (TTM)

BRTX-42384.0%

GOVX-74366.0%

ROA (TTM)

BRTX-19330.0%

GOVX-39473.0%

ROIC (TTM)

BRTX-42384.0%

GOVX-74366.0%

Cash

BRTX$3M

GOVX$3M

Debt

BRTX$0

GOVX$0

Net Cash/Debt

BRTX$3M

GOVX$3M

Current Ratio (TTM)

BRTX2.35x

GOVX1.54x

Quick Ratio (TTM)

BRTX2.23x

GOVX1.16x

Debt/Equity (TTM)

BRTX0.00x

GOVX0.00x

Debt/Assets (TTM)

BRTX0.0%

GOVX0.0%

Interest Coverage (TTM)

BRTXN/A

GOVXN/A

Net Debt/EBITDA (TTM)

BRTX0.00x

GOVX0.00x

Beta

BRTX0.80

GOVX3.89

52W Performance

BRTX-94.2%

GOVX-98.1%

YTD Performance

BRTX-92.2%

GOVX-94.6%

% from 52W High

BRTX-94.5%

GOVX-98.2%

% from 52W Low

BRTX9.1%

GOVX3.9%

Asset Turnover (TTM)

BRTX0.06x

GOVX0.69x

FCF Yield (TTM)

BRTX-24.4%

GOVX-950.7%

Earnings Yield (TTM)

BRTX-22.7%

GOVX-986.3%

Dividend Yield (TTM)

BRTXN/A

GOVXN/A

Rule of 40

BRTX-3,332.8

GOVX-100.0

EV/GP/RG

BRTX2.12

GOVXN/A

Ticker research

View BRTX research View GOVX research

Metric	BRTX BioRestorative Therapies Inc	GOVX GeoVax Labs Inc
Market & Valuation
Market Cap	$49M	$2M
Enterprise Value	$46M	$-1M
Price	$1.91	$0.28
P/E Ratio	N/A	N/A
P/S Ratio	135.98x	0.53x
EV/Sales	127.28x	0.01x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.98x	1.84x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.83x	0.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$358K	$0
Revenue Growth (YoY)	-8.5%	-100.0%
Forward Rev Growth	64.6%	0.0%
Profitability
Gross Margin (TTM)	92.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-3915.8%	0.0%
Net Margin (TTM)	-3089.3%	0.0%
FCF Margin (TTM)	-3324.3%	N/A
Net Income (TTM)	$-11M	$-20M
FCF (TTM)	$-12M	$-20M
EPS (TTM)	-$12.47	-$4.47
ROE (TTM)	-42384.0%	-74366.0%
ROA (TTM)	-19330.0%	-39473.0%
ROIC (TTM)	-42384.0%	-74366.0%
Financial Health
Cash	$3M	$3M
Debt	$0	$0
Net Cash/Debt	$3M	$3M
Current Ratio (TTM)	2.35x	1.54x
Quick Ratio (TTM)	2.23x	1.16x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.80	3.89
52W Performance	-94.2%	-98.1%
YTD Performance	-92.2%	-94.6%
% from 52W High	-94.5%	-98.2%
% from 52W Low	9.1%	3.9%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.69x
FCF Yield (TTM)	-24.4%	-950.7%
Earnings Yield (TTM)	-22.7%	-986.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,332.8	-100.0
EV/GP/RG	2.12	N/A
Ticker research	View BRTX research	View GOVX research